62 companies

Incyte

Market Cap: US$24.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$121.07

7D

0.4%

1Y

48.4%

Exelixis

Market Cap: US$13.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$51.33

7D

-8.3%

1Y

35.3%

Orion Oyj

Market Cap: €11.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€79.35

7D

-1.3%

1Y

19.2%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥53.1b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥117.31

7D

5.6%

1Y

30.9%

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥42.9b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

688336

CN¥46.79

7D

8.9%

1Y

33.0%

Abbott India

Market Cap: ₹595.2b

Operates as a pharmaceutical company in India.

500488

₹28,146.90

7D

1.5%

1Y

-14.7%

3SBio

Market Cap: HK$44.3b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

1530

HK$17.62

7D

2.3%

1Y

-43.3%

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ACAD

US$29.41

7D

8.3%

1Y

15.6%

SK Biopharmaceuticals

Market Cap: ₩7.1t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩88,350.00

7D

7.7%

1Y

-11.8%

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥31.9b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥119.90

7D

8.7%

1Y

6.6%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹439.9b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,619.65

7D

2.1%

1Y

-5.6%

Ajanta Pharma

Market Cap: ₹438.0b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

AJANTPHARM

₹3,541.00

7D

3.0%

1Y

32.5%

Sumitomo Pharma

Market Cap: JP¥603.4b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,348.00

7D

5.9%

1Y

-3.0%

Xiamen Amoytop Biotech

Market Cap: CN¥24.7b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥59.36

7D

3.1%

1Y

-31.8%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥24.7b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

600329

CN¥36.72

7D

-1.6%

1Y

-14.1%

Zealand Pharma

Market Cap: DKK 23.5b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 335.10

7D

5.3%

1Y

-2.3%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€58.35

7D

-1.0%

1Y

7.9%

Neuland Laboratories

Market Cap: ₹294.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

New

524558

₹22,505.60

7D

12.7%

1Y

72.9%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.8b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س141.90

7D

-0.07%

1Y

-11.9%

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

CDNA

US$47.23

7D

0.3%

1Y

279.1%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥15.4b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

300573

CN¥42.19

7D

-0.1%

1Y

-4.9%

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

New

ADMA

US$9.91

7D

11.2%

1Y

-40.9%

HBM Holdings

Market Cap: HK$13.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$15.03

7D

19.2%

1Y

33.5%

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

New

INVA

US$20.75

7D

-0.5%

1Y

3.3%

CORONA Remedies

Market Cap: ₹128.5b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,135.90

7D

1.9%

1Y

n/a

ChemoMetec

Market Cap: DKK 8.3b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 475.00

7D

13.9%

1Y

-5.4%

BioGaia

Market Cap: SEK 11.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 112.20

7D

-1.6%

1Y

19.8%

Oscotec

Market Cap: ₩1.4t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

A039200

₩38,800.00

7D

15.5%

1Y

15.0%

Soho Global Health

Market Cap: Rp15.0t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

SOHO

Rp1,180.00

7D

-1.3%

1Y

56.3%

Zevra Therapeutics

Market Cap: US$681.7m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

New

ZVRA

US$11.34

7D

7.8%

1Y

-3.6%

CorMedix

Market Cap: US$590.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$7.30

7D

-2.9%

1Y

-36.5%

Middle East Pharmaceutical Industries

Market Cap: ر.س2.1b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

4016

ر.س60.35

7D

2.6%

1Y

-13.1%

Rafa Laboratories

Market Cap: ₪1.5b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

RAFA

₪15.65

7D

-2.2%

1Y

n/a

Onconic Therapeutics

Market Cap: ₩674.3b

Engages in the research and development of anti-cancer therapy in South Korea.

A476060

₩15,800.00

7D

21.3%

1Y

156.4%

DHG Pharmaceutical

Market Cap: ₫12.5t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

DHG

₫95,600.00

7D

0.8%

1Y

-6.8%

Q32 Bio

Market Cap: US$466.5m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

New

QTTB

US$15.41

7D

-4.6%

1Y

817.3%

Page 1 of 2